Concise review: cell therapy for critical limb ischemia: an integrated review of preclinical and clinical studies

M Qadura, DC Terenzi, S Verma, M Al-Omran… - Stem …, 2018 - academic.oup.com
Critical limb ischemia (CLI), the most severe form of peripheral artery disease, is
characterized by pain at rest and non-healing ulcers in the lower extremities. For patients …

Modulating the vascular response to limb ischemia: angiogenic and cell therapies

JP Cooke, DW Losordo - Circulation research, 2015 - Am Heart Assoc
The age-adjusted prevalence of peripheral arterial disease in the US population has been
estimated to approach 12%. The clinical consequences of occlusive peripheral arterial …

Global position paper on cardiovascular regenerative medicine

F Fernández-Avilés, R Sanz-Ruiz… - European heart …, 2017 - academic.oup.com
Based on the increasingly understood regenerative capacity of the human heart and
vascular system, 1 cardiovascular regenerative medicine (CRM) encompasses all potential …

[HTML][HTML] Bone marrow derived cell therapy in critical limb ischemia: a meta-analysis of randomized placebo controlled trials

SMOP Weem, M Teraa, GJ De Borst… - European Journal of …, 2015 - Elsevier
Objective/Background Critical limb ischemia (CLI) is the most advanced stage of peripheral
artery disease (PAD), and many patients with CLI are not eligible for conventional …

Current status of angiogenic cell therapy and related strategies applied in critical limb ischemia

L Beltrán-Camacho, M Rojas-Torres… - International Journal of …, 2021 - mdpi.com
Critical limb ischemia (CLI) constitutes the most severe form of peripheral arterial disease
(PAD), it is characterized by progressive blockade of arterial vessels, commonly correlated …

Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease

L Hou, JJ Kim, YJ Woo… - American Journal of …, 2016 - journals.physiology.org
Stem cell therapy is a promising approach for the treatment of tissue ischemia associated
with myocardial infarction and peripheral arterial disease. Stem and progenitor cells derived …

Autologous bone marrow–derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials

M Teraa, RW Sprengers, Y Van Der Graaf… - Annals of …, 2013 - journals.lww.com
Background: Critical Limb Ischemia (CLI) is the most advanced stage of peripheral arterial
disease and is usually treated with bypass surgery or endovascular revascularization …

Stem cell-based peripheral vascular regeneration

Y Fujita, A Kawamoto - Advanced drug delivery reviews, 2017 - Elsevier
Chronic critical limb ischemia (CLI) represents an end-stage manifestation of peripheral
arterial disease (PAD). CLI patients are at very high risk of amputation and cardiovascular …

Effectiveness and safety of stem cell therapy for diabetic foot: a meta-analysis update

Y Sun, J Zhao, L Zhang, Z Li, S Lei - Stem cell research & therapy, 2022 - Springer
Background Diabetic foot (DF) is one of the most common and serious complications of
diabetes mellitus (DM), which brings great psychological and economic pressure to patients …

The multi-differentiation potential of peripheral blood mononuclear cells

M Zhang, B Huang - Stem cell research & therapy, 2012 - Springer
Peripheral blood is a large accessible source of adult stem cells for both basic research and
clinical applications. Peripheral blood mononuclear cells (PBMCs) have been reported to …